FDA warns Curaleaf about inflated claims in CBD product marketing



A major medical marijuana company is under fire from the FDA. The agency sent Curaleaf a letter of warning over concerns that the cannabis company is …

Be the first to comment

Leave a Reply

Your email address will not be published.


*